Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes. - Wikidata - wikimedia - TriplyDB

Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes.

Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes.

http://www.wikidata.org/entity/Q40881501

about

Adipose tissue-derived mesenchymal stem cells and platelet-rich plasma: stem cell transplantation methods that enhance stemness Cell Therapy in Patients with Critical Limb Ischemia Bottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal Cells Stem cell therapy to cure type 1 diabetes: from hype to hope.Diabetes mellitus related bone metabolism and periodontal disease Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus Immunobiology of mesenchymal stem cells Adipose-derived stem cells from diabetic mice show impaired vascular stabilization in a murine model of diabetic retinopathy.Plasminogen activator inhibitor-1 is involved in impaired bone repair associated with diabetes in female mice.Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanism Adipose-derived mesenchymal stem cells improve glucose homeostasis in high-fat diet-induced obese mice Functional tooth restoration by allogeneic mesenchymal stem cell-based bio-root regeneration in swine.Mesenchymal Stem Cells Improve Healing of Diabetic Foot Ulcer.Mesenchymal stem cell therapy in diabetes mellitus: progress and challenges The potential of cell-based therapy for diabetes and diabetes-related vascular complications.Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells.Trophic Activity and Phenotype of Adipose Tissue-Derived Mesenchymal Stem Cells as a Background of Their Regenerative Potential.Type 2 diabetes alters mesenchymal stem cell secretome composition and angiogenic properties.Delivery of antagomiR204-conjugated gold nanoparticles from PLGA sheets and its implication in promoting osseointegration of titanium implant in type 2 diabetes mellitus High glucose induces the aging of mesenchymal stem cells via Akt/mTOR signaling.Autologous Bone Marrow-Derived Stem Cells for Treating Diabetic Neuropathy in Metabolic Syndrome.Human Placenta-Derived Mesenchymal Stromal-Like Cells Enhance Angiogenesis via T Cell-Dependent Reprogramming of Macrophage Differentiation.Deferoxamine preconditioning to restore impaired HIF-1α-mediated angiogenic mechanisms in adipose-derived stem cells from STZ-induced type 1 diabetic rats.Myelotoxicity of carboplatin is increased in vivo in db/db mice, the animal model of obesity-associated diabetes mellitus.Characterization of human adipose tissue-derived stromal cells isolated from diabetic patient's distal limbs with critical ischemia.Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research.

P2860

Q26779051-D09E26B0-36C4-4B36-BBF1-FC70AC50743A Q26795443-6F7FDC05-2569-4FB7-8A7C-F0A1E6AD471F Q26798278-D1905B87-8CC8-4428-8EEC-C158CB38AE92 Q26823294-088E4D5B-4172-473C-8463-074EB3640217 Q26852990-A3329073-FD87-4D87-90A8-50FFAEAE4837 Q26864580-05FAB110-AC19-45D8-BD44-5C9F5675E02B Q27004487-F43DEACA-43C7-452C-A732-789364D50DBE Q30300372-B28F16A1-D902-49AC-AA2E-E032DBBEAB88 Q35126620-B0DEB844-71F6-4705-8846-35B9AEA62BC1 Q35137241-FEC7A7FD-9957-4546-AFF9-4121F557D082 Q36234988-8C5C8D0F-9817-47B1-A6CD-8DEC04AAAE59 Q36889809-5A02A8DA-39AF-4703-8F21-7C68334A384D Q37721027-C152E998-FFE6-473E-A93C-A1864A0AF5CA Q38114073-D54B7368-0274-421D-AC5F-23695C6596D4 Q38181982-28C482F3-54DE-45B3-B2A6-766E5754E8AE Q40883757-F7FFA1A1-EE18-4150-8C29-3C2861717F6F Q41056755-DD157CF3-12F2-4A9D-BED6-BBAED4B7EF13 Q41850843-6BCBAE73-E96F-46DB-9A5D-4E4BAC1228F5 Q42280449-C45F56DB-2D5C-484A-9224-1F7679505F2A Q42347169-FABDAAB0-CAE1-4E31-A38B-A5CD214813FA Q47094987-00ECA83F-D7B9-47B0-B4B6-0ED2FF522238 Q48199182-7D113E25-37C2-48AB-86C9-29EBF0C69E19 Q50565602-E8DEDAC0-D413-43A7-990B-CB9DCEE5210F Q53645576-F4A76991-6971-4242-8E70-24460C544DC9 Q54521735-722EBE34-9D85-41F7-A95B-C7205E7E5205 Q55669443-90F9102C-C059-4B42-987D-7308581D9180

P2860

Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes.

http://www.wikidata.org/entity/Q40881501

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes.

@en

type

label

Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes.

@en

prefLabel

Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes.

@en

P1433

Q40881501-60229E5A-793A-4DA2-935D-66B186115E1F

P1476

Q40881501-3BA7C56B-E1E0-4558-9687-4E08451BDDEF

P2093

Q40881501-2249FC31-D81C-4408-8AC7-6A36217A47AB

Q40881501-F4C20301-0301-415E-AACB-57841829FE96

P2860

Q40881501-0DD7E29B-D6E3-4D75-BD6F-F9F70843BBAD

Q40881501-0F08B8C8-E233-4B1C-A3E3-1871FCFF2AED

Q40881501-138FE2B1-6298-4F4A-AB12-D2D520EDF4A1

Q40881501-16CB1463-D4F9-42F0-97EB-9B486348D817

Q40881501-205C0AE8-E189-4041-A87B-65DD714130F6

Q40881501-230E81B8-F8D4-4F24-ADAD-F00BD33DDBF0

Q40881501-247CB40A-DD46-4888-A58A-8BFF1D1431B9

Q40881501-255385F5-FE40-49D4-A645-FB13DD957BFF

Q40881501-259B832E-3909-40A0-B413-B8E1D34B0B14

Q40881501-279D6662-2889-49FB-ABD1-25955C58D202

P304

Q40881501-90BE5B9E-71EF-43BF-B0CC-78BB186FE30C

P31

Q40881501-150FD3E3-B003-4187-8594-EB8D2E7E194B

P356

Q40881501-1C7B69A1-4AD1-46A1-9A95-D6E024F5BEDB

P433

Q40881501-8FDDDAEB-CED4-4289-9AB8-6247FFE6A1C2

P478

Q40881501-BE59B5FF-7266-4AB0-901C-D3C08AC4794A

P577

Q40881501-A680C92D-03CA-4374-8EE1-1E01301026AE

P5875

Q40881501-891B9895-85A9-4483-91E3-E6D806D8372E

P698

Q40881501-5DA0C73A-45C3-4DD9-9270-78100C480B0D

P921

Q40881501-25841DC2-208A-4CC2-BA18-FC1B877E0D99

P932

Q40881501-EE394215-FCEB-4F9F-901E-84CEA548C018

P356

P1433

Stem Cells Translational Medicine

P1476

Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes.

@en

P2093

Daniel A Peterson

http://www.w3.org/2001/XMLSchema#string

Laura Shin

http://www.w3.org/2001/XMLSchema#string

P2860

Biochemistry and molecular cell biology of diabetic complications

A perivascular origin for mesenchymal stem cells in multiple human organs

The hormone resistin links obesity to diabetes

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes.

Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons

Bone marrow mesenchymal cells: how do they contribute to tissue repair and are they really stem cells?

Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair.

One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues.

P304

125-135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5966/SCTM.2012-0031

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233806456

http://www.w3.org/2001/XMLSchema#string

P698

23197759

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3659680

http://www.w3.org/2001/XMLSchema#string